Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111019604

Fluoxetine Hydrochloride Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111019604 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 g
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-9604 1 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-9604 Supplier MilliporeSigma Supelco Supplier No. PHR13941G
Add to Cart
Add to Cart

Description

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Fluoxetine Hydrochloride is a selective serotonin-reuptake inhibitor used as an antidepressant. It is also utilized for the treatment of obsessive-compulsive disorders. Featured Industries: Pharmaceutical (small molecule)
TRUSTED_SUSTAINABILITY

Specifications

CAS 56296-78-7
Physical Form Neat
Linear Formula C17H18F3 NO · HCl
MDL Number MFCD00214288
Synonym Fluoxetine hydrochloride; (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; LY-110,140 hydrochloride
Type Certified Reference Material
Quantity 1 g
Formula Weight 345.79
Grade Certified Reference Material

Sold under license from Eli Lilly and Company.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.